Browsing Tag
pozdeutinurad
1 post
Sobi bets on late-stage gout asset with acquisition of Arthrosi Therapeutics
Swedish Orphan Biovitrum is acquiring Arthrosi Therapeutics for $950 million to bolster its inflammation pipeline. Explore what this means for its growth trajectory.